Distinct behavioral and pharmacological effects of two benzodiazepine antagonists: Ro 15-1788 and methyl beta-carboline
Prado de Carvalho, L.; Venault, P.; Cavalheiro, E.; Kaijima, M.; Valin, A.; Dodd, R.H.; Potier, P.; Rossier, J.; Chapouthier, G.
Advances in Biochemical Psychopharmacology 38: 175-187
1983
ISSN/ISBN: 0065-2229 PMID: 6142602 Document Number: 201031
Document emailed within 1 workday
Related Documents
Yang, X.M.; Luo, Z.P.; Zhou, J.H. 1989: Behavioral evidence for the role of noradrenaline in the putative anxiogenic actions of the inverse benzodiazepine receptor agonist methyl-4-ethyl-6,7-dimethoxy-beta-carboline-3-carboxylate Journal of Pharmacology and Experimental Therapeutics 250(1): 358-363Talalaenko, A.N. 1989: A pharmacological analysis of the anxiolytic action of derivations of benzodiazepine, GABA and beta-carboline in various tests of tension reaction Farmakologiia i Toksikologiia 52(6): 26-29
Nielsen, M.; Braestrup, C. 1980: Ethyl beta-carboline-3-carboxylate shows differential benzodiazepine receptor interaction Nature 286(5773): 606-607
Löscher, W.; Hönack, D. 1991: Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine Journal of Pharmacology and Experimental Therapeutics 256(2): 432-440
Gee, K.W.; Ehlert, F.J.; Yamamura, H.I. 1983: Differential effect of gamma-aminobutyric acid on benzodiazepine receptor subtypes labeled by [3H]propyl beta-carboline-3-carboxylate in rat brain Journal of Pharmacology and Experimental Therapeutics 225(1): 132-137
Herraiz, T. 2000: Analysis of the bioactive alkaloids tetrahydro-beta-carboline and beta-carboline in food Journal of Chromatography A 881(1-2): 483-499
Vicini, S.; Mienville, J.M.; Costa, E. 1987: Actions of benzodiazepine and beta-carboline derivatives on gamma-aminobutyric acid-activated Cl- channels recorded from membrane patches of neonatal rat cortical neurons in culture Journal of Pharmacology and Experimental Therapeutics 243(3): 1195-1201
Parsons, C.G.; Danysz, W.; Quack, G.; Hartmann, S.; Lorenz, B.; Wollenburg, C.; Baran, L.; Przegalinski, E.; Kostowski, W.; Krzascik, P.; Chizh, B.; Headley, P.M. 1997: Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization Journal of Pharmacology and Experimental Therapeutics 283(3): 1264-1275
Nawrocka, W.; Rutkowska, M.; Szelag, A.; Barczyńska, J.; Kedzierska-Goździk, L.; Błaszczyk, F.; Dziwiszek, W. 1996: Synthesis and pharmacological properties of new derivatives of 4-methyl-5-oxalo-1H-2,3,4,5-tetrahydro-1,5-benzodiazepin-2-one and beta-oxo-5-(4-methyl-1H-2,3,4,5-tetrahydro-1,5-benzodiazepin-2 -one)propionic acid Acta Poloniae Pharmaceutica 53(6): 425-430
Sieghart, W.; Drexler, G.; Mayer, A.; Schuster, A. 1983: Interaction of benzodiazepine agonists and antagonists with different benzodiazepine receptors Advances in Biochemical Psychopharmacology 38: 11-19
Ueda, M.; Masui, M.; Kawakami, M.; Matsunaga, K.; Gemba, T.; Ninomiya, M.; Nakano, A.; Torii, M.; Adachi, I.; Ito, H. 1993: Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 4th communication: prophylactic and therapeutic effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3- b]pyridine-5-carboxylate in stroke-prone spontaneously hypertensive rats Arzneimittel-Forschung 43(12): 1291-1303
Dodd, R.H.; Ouannès, C.; Chiaroni, A.; Riche, C.; Poissonnet, G.; Rossier, J.; Devaux, G.; Potier, P. 1987: Molecular structure of 3-(methoxycarbonyl) amino-beta-carboline, a selective antagonist of the sedative effects of diazepam Molecular Pharmacology 31(1): 74-80
Nakajima, M.; Adachi, I.; Ueda, M. 1993: Pharmacological studies on a new Dihydrothienopyridine calcium antagonist. 2nd communication: effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4- (3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate on the 1,4-dihydropyridine binding sites in the brain and on isolated arteries in the Cynomolgus monkey Arzneimittel-Forschung 43(12): 1276-1282
Sontag, K.H.; Heim, C.; Sontag, T.A.; God, R.; Reichmann, H.; Wesemann, W.; Rausch, W.D.; Riederer, P.; Bringmann, G. 1995: Long-term behavioural effects of TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) after subchronic treatment in rats Journal of Neural Transmission. Supplementum 46: 283-289
Spealman, R.D.; Kelleher, R.T.; Morse, W.H.; Goldberg, S.R. 1981: Supersensitivity to the behavioral effects of opiate antagonists Psychopharmacology Bulletin 17(1): 54-56
Buckley, J.P.; Steenberg, M.L.; Barry, H.; Manian, A.A. 1974: Pharmacological and behavioral effects of mono- and disubstituted chlorpromazine derivatives Advances in Biochemical Psychopharmacology 9: 617-631
Piascik, M.F.; Rahwan, R.G.; Witiak, D.T. 1978: Pharmacological evaluation of new calcium antagonists: 2-substituted 3-dimethylamino-5,6-methylenedioxyindenes. Effects on adrenomedullary catecholamine secretion Journal of Pharmacology and Experimental Therapeutics 205(1): 155-163
Peczyńska-Czoch, W. 1987: Microbial transformation of azacarbazoles. V. Studies on N-1 methylation of 4-methyl-alpha-carboline by Kitasatosporia setae strain Archivum Immunologiae et Therapiae Experimentalis 35(2): 117-124
Ohno, M.; Yamamoto, T.; Watanabe, S. 1992: Effects of intrahippocampal injections of N-methyl-D-aspartate receptor antagonists and scopolamine on working and reference memory assessed in rats by a three-panel runway task Journal of Pharmacology and Experimental Therapeutics 263(3): 943-950
Sansone, M.; Castellano, C.; Pavone, F.; Hano, J. 1985: Opioid benzodiazepine tifluadom and drug-induced hyperactivity in mice: lack of benzodiazepine-like effects Polish Journal of Pharmacology and Pharmacy 37(5): 585-590